SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
-11.5%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.63B
AUM Growth
+$2.63B
(-20%)
Cap. Flow
-$267M
Cap. Flow
% of AUM
-10.16%
Top 10 Holdings %
Top 10 Hldgs %
36.43%
Holding
110
New
23
Increased
22
Reduced
18
Closed
21
Top Buys
| 1 |
Canadian Pacific Kansas City
CP
|
$44.3M |
| 2 |
Royalty Pharma
RPRX
|
$44.3M |
| 3 |
XYZ
Block, Inc.
XYZ
|
$41.8M |
| 4 |
Viatris
VTRS
|
$40.6M |
| 5 |
Fidelity National Information Services
FIS
|
$40.6M |
Top Sells
| 1 |
Amazon
AMZN
|
$147M |
| 2 |
Microsoft
MSFT
|
$88.8M |
| 3 |
S&P Global
SPGI
|
$84.8M |
| 4 |
Charles Schwab
SCHW
|
$82.9M |
| 5 |
Johnson & Johnson
JNJ
|
$73.6M |
Sector Composition
| 1 | Healthcare | 56.33% |
| 2 | Industrials | 11.58% |
| 3 | Consumer Discretionary | 10.43% |
| 4 | Technology | 7.11% |
| 5 | Financials | 5.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Fidelity National Information Services
FIS
$35.6B
| $40.6M | 1.55% |
+443,240
| New | +$40.6M |
|
27
Hilton Worldwide
HLT
$64.7B
| $40.2M | 1.53% |
360,491
-2,212
| -0.6% | -$247K |
|
28
Marriott International Class A Common Stock
MAR
$72B
| $39.8M | 1.51% |
292,687
-16,553
| -5% | -$2.25M |
|
|
HZNP
29
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $38.8M | 1.48% |
+486,661
| New | +$38.8M |
|
30
Kezar Life Sciences
KZR
$28.5M
| $36.5M | 1.39% |
4,412,300
+3,002,344
| +213% | +$24.8M |
|
31
McKesson
MCK
$85.9B
| $34.2M | 1.3% |
104,802
+6,822
| +7% | +$2.23M |
|
32
Walt Disney
DIS
$211B
| $33.1M | 1.26% |
+350,926
| New | +$33.1M |
|
33
Global Payments
GPN
$21B
| $31.8M | 1.21% |
+287,222
| New | +$31.8M |
|
|
KDNY
34
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $31.2M | 1.19% |
1,784,200
+350,000
| +24% | +$6.12M |
|
35
RH
RH
$4.14B
| $28.3M | 1.08% |
133,325
-48,510
| -27% | -$10.3M |
|
36
Marqeta
MQ
$2.77B
| $28.1M | 1.07% |
3,463,704
-586,246
| -14% | -$4.75M |
|
37
Exxon Mobil
XOM
$477B
| $24.9M | 0.95% |
+290,732
| New | +$24.9M |
|
38
Sutro Biopharma
STRO
$85.6M
| $24.2M | 0.92% |
4,645,000
+912,600
| +24% | +$4.75M |
|
39
EyePoint Pharmaceuticals
EYPT
$827M
| $23.4M | 0.89% |
2,968,207
+58,800
| +2% | +$463K |
|
40
GFL Environmental
GFL
$17.8B
| $23.3M | 0.89% |
903,132
-1,381,364
| -60% | -$35.6M |
|
41
Monster Beverage
MNST
$62B
| $23.2M | 0.88% |
+249,802
| New | +$23.2M |
|
42
Crinetics Pharmaceuticals
CRNX
$3.26B
| $21M | 0.8% |
+1,125,112
| New | +$21M |
|
43
Ultragenyx Pharmaceutical
RARE
$3.04B
| $20.8M | 0.79% |
348,519
-176,581
| -34% | -$10.5M |
|
|
PNT
44
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $20.5M | 0.78% |
3,014,408
| – | – |
|
45
Match Group
MTCH
$9.04B
| $20.1M | 0.76% |
+287,786
| New | +$20.1M |
|
46
KalVista Pharmaceuticals
KALV
$713M
| $19M | 0.72% |
1,928,200
+181,900
| +10% | +$1.79M |
|
47
Pharvaris
PHVS
$1.41B
| $18.3M | 0.7% |
827,540
| – | – |
|
|
MRNS
48
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $17M | 0.65% |
3,510,831
+744,831
| +27% | +$3.6M |
|
49
Fulcrum Therapeutics
FULC
$353M
| $16.4M | 0.63% |
3,355,624
+742,212
| +28% | +$3.64M |
|
50
ServiceNow
NOW
$191B
| $12.1M | 0.46% |
+25,521
| New | +$12.1M |
|